Total Funding
77
64
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3438
Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.
- Kirti Desai: Chief Financial Officer
- Sadiq Khan: Chief Commercial Officer
About the Company
Tevogen Bio is a clinical-stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several
breakthrough cell and gene therapy platforms.
South Asian Led
